ANXA5 and chronic myelogenous leukemia, BCR-ABL1 positive: Therefore, the percentages of apoptotic cells were determined using annexin V/PI staining, once CD34+ cells from patients with CML in the megakaryocytic and myeloid crisis phases had been exposed to imatinib for 24 to 72 h.